Sean Johnston
Chief Executive Officer at IGNYTA INC
Profile
Sean A.
Johnston is currently the Chief Executive Officer & Secretary at Anadys Pharmaceuticals, Inc., Ignyta, Inc., Jecure Therapeutics, Inc., and Director at Roche Holdings, Inc., Kapa Biosystems, Inc., GenMark Diagnostics, Inc., IQuum, Inc., and Spark Therapeutics, Inc. He previously worked as a Research Scientist at XOMA Corp.
and International Genetic Engineering, Inc. Johnston received his undergraduate degree from Stanford University, doctorate from the University of California, Los Angeles, and another undergraduate degree from the University of California, Davis.
Sean Johnston active positions
| Companies | Position | Start |
|---|---|---|
| IGNYTA INC | Chief Executive Officer | 08/02/2018 |
| SPARK THERAPEUTICS, INC. | Director/Board Member | 17/12/2019 |
| GENMARK DIAGNOSTICS, INC. | Director/Board Member | 22/04/2021 |
Roche Holdings, Inc.
 Roche Holdings, Inc. Pharmaceuticals: MajorHealth Technology Roche Holdings, Inc. operates as a holding company, which engages in the manufacture and distribution of pharmaceutical and vitamin products. It also provides financial services to other members of the RHI Group and to refinance on the bond or loan markets. The company was founded in 1987 and is headquartered in San Francisco, CA. | Director/Board Member | 17/02/2017 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Compliance Officer | - |
Jecure Therapeutics, Inc.
 Jecure Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Jecure Therapeutics, Inc. provides therapeutic services for the treatment of non-alcoholic steatohepatitis (NASH) and liver fibrosis. The company was founded by Ariel Feldstein in 2015 and is headquartered in San Diego, CA. | Chief Executive Officer | - |
Kapa Biosystems, Inc.
 Kapa Biosystems, Inc. BiotechnologyHealth Technology Kapa Biosystems, Inc. provides genomic tools. It develops solutions that accelerate genomics research to diagnose, monitor, and treat cancer and complex inherited and infectious diseases. The company was founded by John Foskett, Paul McEwan, Ron McEwan, and Christopher McGuinness in 2006 and is headquartered in Wilmington, MA. | Director/Board Member | - |
IQuum, Inc.
 IQuum, Inc. Pharmaceuticals: MajorHealth Technology IQuum, Inc. designs and develops biological molecular diagnostics products. It develops lab-in-a-tube technology, a novel biological sample testing platform which provides revolutionary benefits to a broad cross section of the bioassay market. The firm''s proprietary technology enables the non-specialized personnel to perform more sophisticated biological sample testing in any setting with greater speed. The company was founded by Shuqi Chen and Keith Greenfield in 1998 and is headquartered in Marlborough, MA. | Director/Board Member | - |
Anadys Pharmaceuticals, Inc.
 Anadys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Anadys Pharmaceuticals, Inc. develops and manufactures novel small molecule medicines. It engages in developing novel medicines in the areas of hepatitis C and oncology. The firm develops ANA598, a direct-acting antiviral for the treatment of hepatitis C. The company was founded by Stelios B. Papadopoulos and Kleanthis G. Xanthopoulos in 1992 and is headquartered in Little Falls, NJ. | Chief Executive Officer | - |
Former positions of Sean Johnston
| Companies | Position | End |
|---|---|---|
| ░░░░ ░░░░░░░░░░░ | ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ | - |
| ░░░░░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ | - |
Training of Sean Johnston
| Stanford University | Undergraduate Degree |
| University of California, Los Angeles | Doctorate Degree |
| University of California, Davis | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| XOMA CORPORATION | Health Technology |
| Private companies | 10 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
Roche Holdings, Inc.
Roche Holdings, Inc. Pharmaceuticals: MajorHealth Technology Roche Holdings, Inc. operates as a holding company, which engages in the manufacture and distribution of pharmaceutical and vitamin products. It also provides financial services to other members of the RHI Group and to refinance on the bond or loan markets. The company was founded in 1987 and is headquartered in San Francisco, CA. | Health Technology |
Anadys Pharmaceuticals, Inc.
Anadys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Anadys Pharmaceuticals, Inc. develops and manufactures novel small molecule medicines. It engages in developing novel medicines in the areas of hepatitis C and oncology. The firm develops ANA598, a direct-acting antiviral for the treatment of hepatitis C. The company was founded by Stelios B. Papadopoulos and Kleanthis G. Xanthopoulos in 1992 and is headquartered in Little Falls, NJ. | Health Technology |
Kapa Biosystems, Inc.
Kapa Biosystems, Inc. BiotechnologyHealth Technology Kapa Biosystems, Inc. provides genomic tools. It develops solutions that accelerate genomics research to diagnose, monitor, and treat cancer and complex inherited and infectious diseases. The company was founded by John Foskett, Paul McEwan, Ron McEwan, and Christopher McGuinness in 2006 and is headquartered in Wilmington, MA. | Health Technology |
GenMark Diagnostics, Inc.
 GenMark Diagnostics, Inc. Medical SpecialtiesHealth Technology GenMark Diagnostics, Inc. engages in the development, manufacturing, sales, and support of instruments and molecular tests based on its proprietary eSensor detection technology. Its solutions include ePlex System and XT-8 System. The company was founded by Jon Faiz Kayyem in 1993 and is headquartered in Carlsbad, CA. | Health Technology |
IQuum, Inc.
IQuum, Inc. Pharmaceuticals: MajorHealth Technology IQuum, Inc. designs and develops biological molecular diagnostics products. It develops lab-in-a-tube technology, a novel biological sample testing platform which provides revolutionary benefits to a broad cross section of the bioassay market. The firm''s proprietary technology enables the non-specialized personnel to perform more sophisticated biological sample testing in any setting with greater speed. The company was founded by Shuqi Chen and Keith Greenfield in 1998 and is headquartered in Marlborough, MA. | Health Technology |
International Genetic Engineering, Inc.
 International Genetic Engineering, Inc. Engineering & ConstructionIndustrial Services International Genetic Engineering, Inc. provides engineering services. The private company is based in Santa Monica, CA. The company was founded by Gary L. Wilcox. | Industrial Services |
Ignyta, Inc.
 Ignyta, Inc. BiotechnologyHealth Technology Ignyta, Inc. operates as a medicine biotechnology company. The firm engages in the discovering, acquiring, developing and commercializing targeted new drugs for cancer patients. The company was founded by Jonathan E. Lim on September 13, 2011 and is headquartered in South San Francisco, CA. | Health Technology |
Spark Therapeutics, Inc.
 Spark Therapeutics, Inc. BiotechnologyHealth Technology Spark Therapeutics, Inc. engages in the research, development, and commercialization of gene therapies. Its product portfolio intends to treat inherited retinal sickness, liver-mediated, and neurodegenerative diseases. The company was founded by Jean Bennett, Beverly Davidson, Katherine A. High, Jeffrey D. Marrazzo, J. Fraser Wright, and Jennifer Wellman on March 13, 2013 and is headquartered in Philadelphia, PA. | Health Technology |
Jecure Therapeutics, Inc.
Jecure Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Jecure Therapeutics, Inc. provides therapeutic services for the treatment of non-alcoholic steatohepatitis (NASH) and liver fibrosis. The company was founded by Ariel Feldstein in 2015 and is headquartered in San Diego, CA. | Commercial Services |
- Stock Market
- Insiders
- Sean Johnston
